In het kort
Research into a new birth control pill in the Netherlands has been discontinued. The decision was made due to insufficient effectiveness and safety concerns, specifically an increased risk of pregnancies, including those occurring outside the uterus. The hospital involved has stopped testing the pill.
Feiten over dit nieuwsbericht
- 1
Research into a new birth control pill in the Netherlands has been halted.
- 2
The discontinuation is due to insufficient effectiveness and safety concerns.
- 3
Too many women became pregnant during the trial.
- 4
There are concerns about an increased risk of ectopic pregnancies.
- 5
The hospital involved has stopped testing the pill.
Hoe de media berichten
5 artikelen · 5 invalshoeken
“Highlights that research on a new birth control pill was halted due to concerns about pregnancies occurring outside the uterus.”
Onderzoek nieuwe anticonceptiepil gestopt: te veel vrouwen met buitenbaarmoederlijke zwangerschap
Lees meer“Focuses on the halting of research for a new birth control pill, citing an increased risk of ectopic pregnancies among participants.”
Onderzoek naar nieuwe pil als anticonceptiemiddel in Nederland stopgezet
Lees meer“Announces that research into a new birth control pill in the Netherlands has been stopped.”
Ziekenhuis stopt met test nieuwe pil: te veel vrouwen zwanger geworden
Lees meer“States that a hospital has stopped testing a new pill because too many women became pregnant during the trial.”
LUMC stopt met veelbelovende anticonceptiepil: te veel zwangerschappen
Lees meer“Reports that a promising new birth control pill using mifepristone has been discontinued due to insufficient effectiveness and safety, leading to too many pregnancies.”
Achtergrond
Specifically, the research was discontinued because too many women participating in the trial became pregnant. Further concerns were raised regarding an increased risk of ectopic pregnancies, where a pregnancy occurs outside the uterus. These issues led to the cessation of the trial for the new contraceptive pill.
The pill, which utilized mifepristone, was considered promising but ultimately deemed insufficiently effective and safe for continued testing.
